C Test Medicals launches swivel biopsy test for early detection and prevention of oral cancer
C Test Medicals has introduced the swivel biopsy test for the early detection and prevention of oral cancer. The patented C Test comprises of a one simple, easy-to-use kit which can detect oral cancer 4 to 5 years in advance, which is even before malignancy strikes.
The Bengaluru-based company claims it to be the world’s first swivel biopsy test. “The early detection and prevention of oral cancer can now become a reality thanks to over a decade of hard work and research and some pioneering work by Dr. Zahra Hussaini, managing director, C Test Medicals Pvt Ltd.” stated the release.
The Cyto test or brush biopsy as compared to pap smear is one part of it and the other is the C swivel biopsy which is a modified punch biopsy. The major advantages of the C Test kit are digitalized reporting pattern and a turnaround time of 3 days. It is also painless, and does not require anaesthetic or suturing. This test has been specifically developed for oral cancer and is completely sterile with disposable tips and also easy packaging for transportation of biopsy sample. More importantly at a very cost effective price that is easily affordable to all sections of society, stated Dr Hussaini.
The other technical advantage is the high rate of accuracy owing to the dual test format of brush & swivel and the digitalized reporting, she added.
At the launch of the device in Bengaluru, Fahim Ali, director, C Test Medicals was present along with Viveck Shettyy, motivational speaker and moderator and India’s former cricketer and wicket keeper Syed Mujtaba Hussain Kirmani.